Industry News
Pharmaceutical Industry News
Leucid Bio taps Lonza’s production expertise for a phase 1 CAR-T therapy trial
Leucid Bio taps Lonza’s production expertise for a phase 1 CAR-T therapy trial jkeenan Thu, 12/02/2021 - 08:16
Aspen Pharmacare, pursuing J&J vaccine license, aims to shore up local capacity and quash shot inequality in Africa
Aspen Pharmacare, pursuing J&J vaccine license, aims to shore up local capacity and quash shot inequality in Africa fkansteiner Thu, 12/02/2021 - 07:59
What Can One Life Tell Us About the Battle Against H.I.V.?
In 2001, U.N. estimates suggested 150 million people would be infected with H.I.V. by 2021. That preceded an ambitious global campaign to curb the virus. How well did it work?
Omicron Is Here. Will We Use Our New Covid Drugs Wisely?
The world must not repeat history by making Covid-19 drugs inaccessible.
Fujifilm socks $530M into U.K. vaccine, gene therapy and microbial production, creating 350 jobs
Fujifilm socks $530M into U.K. vaccine, gene therapy and microbial production, creating 350 jobs fkansteiner Wed, 12/01/2021 - 16:45
Sanofi aims to double vaccine sales by 2030, citing RSV and flu market expansion as key drivers
Sanofi aims to double vaccine sales by 2030, citing RSV and flu market expansion as key drivers esagonowsky Wed, 12/01/2021 - 13:51
Moderna loses bid to invalidate vaccine delivery patents, teeing up potential infringement lawsuit
Moderna loses bid to invalidate vaccine delivery patents, teeing up potential infringement lawsuit fkansteiner Wed, 12/01/2021 - 12:42
VBI Vaccines scores first FDA vaccine nod just as the hepatitis B market is set to expand
VBI Vaccines scores first FDA vaccine nod just as the hepatitis B market is set to expand kdunleavy Wed, 12/01/2021 - 10:46
Get ready for M&A: Large biopharma companies will have $1.7T in dealmaking firepower next year, analyst says
Get ready for M&A: Large biopharma companies will have $1.7T in dealmaking firepower next year, analyst says aliu Wed, 12/01/2021 - 09:55
Amgen stalls Samsung’s Enbrel biosim until 2029 in 2nd patent win of the year
Amgen stalls Samsung's Enbrel biosim until 2029 in 2nd patent win of the year fkansteiner Wed, 12/01/2021 - 08:40
Build Back Better Act Would Patch Holes in Health Coverage
Taken together, the provisions in the social policy bill represent the biggest step toward universal coverage since the passage of the Affordable Care Act.
Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panel
The treatment, known as molnupiravir, could be authorized in the United States within days, and available within weeks, if the F.D.A. follows the committee’s recommendation.
Merck’s COVID-19 antiviral narrowly clears FDA panel—but committee echos support for revoking nod in favor of superior option
Merck's COVID-19 antiviral narrowly clears FDA panel—but committee echos support for revoking nod in favor of superior option kdunleavy Tue, 11/30/2021 - 18:37
South African Company Nears License to Sell J. & J. Covid Shot Across Africa
The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen to make the ingredients in the vaccine.
Biogen takes another blow as appeal for Tecfidera patent revival falls short
Biogen takes another blow as appeal for Tecfidera patent revival falls short fkansteiner Tue, 11/30/2021 - 15:13
After flunking key trial, Deciphera cuts 140 jobs, halts development of two drugs
After flunking key trial, Deciphera cuts 140 jobs, halts development of two drugs kdunleavy Tue, 11/30/2021 - 14:14
GSK’s ViiV looks to future of injectable HIV treatment as long-acting PrEP decision looms
GSK's ViiV looks to future of injectable HIV treatment as long-acting PrEP decision looms fkansteiner Tue, 11/30/2021 - 11:10
Bristol Myers Squibb’s next-gen autoimmune med starts high-stakes FDA review amid classwide JAK scrutiny
Bristol Myers Squibb's next-gen autoimmune med starts high-stakes FDA review amid classwide JAK scrutiny aliu Tue, 11/30/2021 - 10:30
Moderna, Regeneron warn about the effectiveness of COVID-19 drugs, vaccines against the omicron variant
Moderna, Regeneron warn about the effectiveness of COVID-19 drugs, vaccines against the omicron variant kdunleavy Tue, 11/30/2021 - 09:57
Seelos eyes chronic ketamine dosing after bagging rights to sublingual candidate
Seelos eyes chronic ketamine dosing after bagging rights to sublingual candidate ntaylor Tue, 11/30/2021 - 09:13